| Breakdown | TTM | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 138.67M | 130.47M | 139.48M | 148.73M | 124.92M | 84.37M |
| Gross Profit | 39.92M | 40.42M | 41.93M | 40.09M | 34.07M | 22.00M |
| EBITDA | 12.96M | 13.43M | 13.71M | 11.93M | 9.69M | 4.17M |
| Net Income | 487.00K | 1.84M | 4.21M | 4.68M | 1.86M | -1.41M |
Balance Sheet | ||||||
| Total Assets | 94.38M | 94.63M | 98.86M | 95.03M | 88.57M | 86.50M |
| Cash, Cash Equivalents and Short-Term Investments | 6.74M | 7.20M | 6.00M | 8.88M | 6.99M | 8.52M |
| Total Debt | 13.06M | 11.19M | 7.65M | 8.52M | 6.85M | 10.23M |
| Total Liabilities | 40.60M | 40.17M | 46.13M | 45.00M | 41.96M | 42.51M |
| Stockholders Equity | 53.77M | 54.45M | 52.73M | 50.03M | 46.61M | 43.98M |
Cash Flow | ||||||
| Free Cash Flow | 2.16M | 2.19M | 3.21M | 4.06M | 3.14M | 6.00K |
| Operating Cash Flow | 8.47M | 5.77M | 8.71M | 10.23M | 8.26M | 2.14M |
| Investing Cash Flow | -3.91M | -4.82M | -6.58M | -5.60M | -4.74M | -1.32M |
| Financing Cash Flow | -1.46M | 349.00K | -5.01M | -2.73M | -5.06M | -4.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £1.37B | 8.23 | 23.46% | 3.08% | -1.17% | 12.31% | |
73 Outperform | £2.01B | 12.50 | 24.53% | 2.49% | 6.93% | 21.50% | |
72 Outperform | £502.28M | 7.10 | 27.48% | 3.65% | 5.78% | -6.80% | |
70 Neutral | £43.02M | 10.36 | 11.64% | 7.35% | -25.56% | -42.49% | |
68 Neutral | £46.59M | 9.18 | 4.00% | 2.45% | 5.54% | 209.72% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | £36.79M | 2,272.39 | 0.90% | 3.29% | -6.46% | -56.20% |